AI在2025年通过改进规划、选址和保留病人,加速临床试验,导致已完成试验增加14.2%。 AI is speeding up clinical trials in 2025 by improving planning, site selection, and patient retention, leading to a 14.2% rise in completed trials.

截至2025年10月,人工智能通过改善试验规划,地点选择和患者保留来加速临床研究,Sitetrove+和Trialtrove+等工具帮助团队减少查失败并提高招生率. As of October 2025, AI is accelerating clinical research by improving trial planning, site selection, and patient retention, with tools like Sitetrove+ and Trialtrove+ helping teams reduce screen failures and boost enrollment. 2024年完成的工业试验增加了14.2%,这反映出数据驱动战略日益成功,得到经更新的ICH E6(R3)准则的支持。 A 14.2% rise in completed industry trials in 2024 reflects growing success from data-driven strategies, supported by updated ICH E6(R3) guidelines. 像Merck这样的公司正在将AI纳入现代化的平台,以精简业务、增强包容性和加快试验速度,同时优先考虑道德使用、透明度和以人为本的设计,以建立信任和确保公平结果。 Companies like Merck are integrating AI into modernized platforms to streamline operations, enhance inclusivity, and speed trials, while prioritizing ethical use, transparency, and human-centered design to build trust and ensure equitable outcomes.